Policy & Regulation
30 January 2023 - Drug discovery company Charles River Laboratories International Inc (NYSE: CRL) disclosed on Monday that it has acquired the remaining 80% ownership stake in SAMDI Tech Inc, a provid...
30 January 2023 - Alpha Biopharma, a China-based developer of innovative drugs, announced on Sunday that the company's New Drug Application (NDA) for Zorifertinib, a next-generation EGFR-TKI, has...
30 January 2023 - Asep Medical Holdings Inc. (CSE: ASEP) (OTCQB: SEPSF), a Canada-based company dedicated to addressing antibiotic failure by developing novel solutions for significant unmet medical n...
30 January 2023 - InDex Pharmaceuticals Holding AB (publ), a Sweden-based pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatme...
30 January 2023 - Loxo@Lilly, the oncology unit of US-based Eli Lilly and Company (NYSE: LLY), announced on Friday that the company has received approval for Jaypirca (pirtobrutinib, 100mg & 50mg ...
30 January 2023 - Marengo Therapeutics, Inc., a US-based company involved in novel therapeutics targeting the T cell receptor (TCR) V-beta to selectively activate the right T cell subsets to fight can...